—

Teva Pharma Industries Ltd ADR (TEVA) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 46 out of 100 (momentum 89 · quality 49 · valuation 42), as of 2026-11-03.
  • Signal: Uptrend stack intact — Trades +4% vs the 50-day and +17.6% vs the 200-day average, 4.4% below the 52-week high and +103.7% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Teva Pharma Industries Ltd ADR trades 4.0% above its 50-day and 17.6% above its 200-day moving average. (as of 2026-11-02)

Teva makes and sells generic medicines across many dosage forms alongside branded treatments for the nervous system, respiratory illness and cancer, and supplies active ingredients and contract manufacturing to other drugmakers. It licenses products to other pharmaceutical firms and has agreements with partners such as Sanofi and Alvotech.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the TEVA overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +4% vs the 50-day and +17.6% vs the 200-day average, 4.4% below the 52-week high and +103.7% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on TEVA?

Uptrend stack intact — Trades +4% vs the 50-day and +17.6% vs the 200-day average, 4.4% below the 52-week high and +103.7% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is TEVA above its 50-day and 200-day moving averages?

As of 2026-11-02, Teva Pharma Industries Ltd ADR trades +4% above its 50-day and +17.6% above its 200-day average, with the 20-day +0.3% away.

How far is TEVA from its 52-week high?

4.4% below the 52-week high and 103.7% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.